Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: Comparison with famotidine

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 5, 2007, Pages 1003-1006

  Ikawa, Kazuro ^a   Shimatani, Tomohiko ^a   Hayato, Seiichi ^a   Morikawa, Norifumi ^a   Tazuma, Susumu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Famotidine; Lafutidine; Pharmacodynamics; Pharmacokinetics

Indexed keywords

FAMOTIDINE; LAFUTIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MECHANISM; GASTRIC PH MONITORING; HUMAN; HUMAN EXPERIMENT; HYSTERESIS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; POSTPRANDIAL STATE; SIGMOID;

ABSORPTION; ACETAMIDES; ADMINISTRATION, ORAL; ADULT; FAMOTIDINE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PIPERIDINES; POSTPRANDIAL PERIOD; PYRIDINES; TABLETS; TIME FACTORS;

EID: 34248165909     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1003     Document Type: Article

References (12)

1. Onodera S., Shibata M., Tanaka M., Inaba N., Yamaura T., Ohnishi H., Jpn. J. Pharmacol., 68, 161-173 (1995).
2. Inaba N., Shibata M., Onodera S., Tanaka M., Suzuki T., Yamaura T., Ohnishi H., Nippon Yakurigaku Zasshi, 105, 231-241 (1995).
3. Saitoh T., Otsuka H., Hirakawa J., Ishikawa M., Takahashi H., Mori H., Ohkawa S., J. Gastroenterol. Hepatol., 17 (Suppl.), A828 (2002).
4. Shimatani T., Inoue M., Kuroiwa T., Horikawa Y., Mieno H., Nakamura M., Aliment. Pharmacol. Ther., 18, 1149-1157 (2003).
5. Itoh H., Naito T., Takeyama M., Biol. Pharm. Bull., 25, 379-382 (2002).
6. Dowling T. C., Frye R. F., J. Chromatogr. B, Biomed. Sci. Appl., 732, 239-243 (1999).
7. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
8. Holford N. H., Sheiner L. B., Clin. Pharmacokinet., 6, 429-453 (1981).
9. Haruki S., Matsumoto H., Kodama K., Takebe M., Takayanagi H., Cyong J. C., Jpn. Pharmacol. Ther., 23, 3049-3059 (1995).
10. Inotsume N., Nishimura M., Fujiyama S., Sagara K., Sato T., Imai Y., Matsui H., Nakano M., Eur. J. Clin. Pharmacol., 36, 517-520 (1989).
11. Lin J. H., Chremos A. N., Kanovsky S. M., Schwartz S., Yeh K. C., Kann J., Br. J. Clin. Pharmacol., 24, 551-553 (1987).
12. Echizen H., Shoda R., Umeda N., Ishizaki T., Clin. Pharmacol. Ther., 44, 690-698 (1988).